BTIG Maintains Buy on Abbott Laboratories, Raises Price Target to $134

Benzinga · 3d ago
BTIG analyst Marie Thibault maintains Abbott Laboratories (NYSE:ABT) with a Buy and raises the price target from $131 to $134.